THE ROLE OF MATRIX METALLOPROTEINASES IN PROCESSES OF HEART RE-MODELING IN CHILDREN WITH RESTRICTIVE CARDIOMYOPATHY
Abstract
Key words: children, chronic heart failure, restrictive cardiomyopathy, matrix metalloproteinases.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2009;8(5):36-39)
About the Authors
T.V. BershovaRussian Federation
A.G. Gasanov
Russian Federation
A.P. Ivanov
Russian Federation
E.V. Basargina
Russian Federation
M.I. Bakanov
Russian Federation
R.B. Zurabova
Russian Federation
References
1. Sivasankaran S. Restrictive cardiomyopathy in India: the story of a vanishing mystery. J. Heart. 2009; 95 (1): 9–14.
2. Salemi V., Leite J., Picard M. et al. Echocardiographic predictors of functional capacity in endomyocardial fibrosis patients. Eur. J. Echocardiogr. 2009; 10: 400–405.
3. Pinto J., Parvatiyar M., Jones M. Troponin T mutation that causes infantile restrictive cardiomyopathy increases Ca2+ sensitivity of force development and impairs the inhibitory properties of troponin. J. Biol. Chem. 2008; 283 (4): 2156–2166.
4. Kaski J., Syrris P., Burch M. et al. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes. J. Heart. 2008; 94 (11): 1478 – 1484.
5. Hosenpud J., Nites N. Clinical, hemodynamic and endomyocardial biopsy findings in idiopathic restrictive cardiomyopathy. West. J. Med. 1986; 44 (3): 303 – 306.
6. Hsu D., Pearson G. Heart failure in children: history, etiology, and pathophysiology. Circ. Heart. Fail. 2009; 2: 63–70.
7. Gonzalez A., Lopez B., Ravassa S. et al. Biochemical markers of myocardial remodelling in hypertensive heart disease. Cardiovasc. Res. 2009; 81 (3): 509–518.
8. Martos R., Baugh J., Ledwidge M. et al. Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover. Eur. J. Heart. Fail. 2009; 11 (2): 191–197.
9. Иванов А.П., Исаев И.И. Эхокардиографические параметры здоровых детей дошкольного и школьного возраста. Педиатрия. 1987; 12: 17–20.
10. Басаргина Е.Н. Кардиомиопатии у детей, сопровождающиеся синдромом хронической сердечной недостаточности. Автореф. дис. … докт. мед. наук. М. 2003. 46 с.
11. Hayashi T., Shimomura H., Terasaki F. et al. Collagen subtypes and matrix metalloproteinase in idiopathic restrictive cardiomyopathy. Int. J. Cardiol. 1998; 64 (2): 109–116.
12. Bigg H., Rowan A., Barker M. et al. Activity of matrix metalloproteinase-9 against native collagen types I and III. J. FEBS 2007; 274 (5): 1246–1255.
13. Rouet-Benzineb P., Buhler J., Dreyfus P. et al. Altered balance between matrix gelatinases (MMP–2 and MMP–9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP–9 in myosin heavy chain degradation. Eur. J. Heart Fail. 1999; 1 (4): 337–352.
14. Welsh P., Whincup P., Papacosta O. et al. Serum matrix metalloproteinase-9 and coronary heart disease: a prospective study in middle aged men. Q.J.M. 2008; 101 (10): 785–791.
15. Zhang W., Zhong M., Yang G. et al. Matrix metalloproteinase–9/tissue inhibitors of metalloproteinase-1 expression and atrial structural remodeling in a dog model of atrial fibrillation: inhibition with angiotensin converting enzyme. Cardiovasc. Pathol. 2008; 17 (6): 399–409.
16. Yasmin S., McEniery C., Wallace S. et al. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler. Thromb. Vasc. Biol. 2005; 25 (2): 372–378.
17. Rude M., Duhaney T., Kuster G. et al. Aldosterone stimulates matrix metalloproteinases and reactive oxygen species in adult rat ventricular cardiomyocytes. Hypertension. 2005: 46 (3): 555–561.
18. Marcy T., Ripley T. Aldosterone antagonists in the treatment of heart failure. Am. J. Health Syst. Pharm. 2006; 63 (1): 49–58.
19. Jeong Y., Chaupin D., Matsushita K. et al. Aldosterone activates endothelial exocytosis. PNAS. 2009; 106 (10): 3782–3787.
Review
For citations:
Bershova T., Gasanov A., Ivanov A., Basargina E., Bakanov M., Zurabova R. THE ROLE OF MATRIX METALLOPROTEINASES IN PROCESSES OF HEART RE-MODELING IN CHILDREN WITH RESTRICTIVE CARDIOMYOPATHY. Current Pediatrics. 2009;8(5):36-39.
Email this article 
